Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8CR0

Crystal structure of human carbonic anhydrase II in complex with a triazolyl benzoxaborole inhibitor

Summary for 8CR0
Entry DOI10.2210/pdb8cr0/pdb
DescriptorCarbonic anhydrase 2, ZINC ION, DIMETHYL SULFOXIDE, ... (5 entities in total)
Functional Keywordsbenzoxaborole, boron, zinc enzyme, complex, lyase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight29774.71
Authors
Alterio, V.,De Simone, G.,Esposito, D. (deposition date: 2023-03-07, release date: 2023-06-21, Last modification date: 2024-02-07)
Primary citationNocentini, A.,Bonardi, A.,Bazzicalupi, C.,Alterio, V.,Esposito, D.,Monti, S.M.,Smietana, M.,De Simone, G.,Supuran, C.T.,Gratteri, P.,Winum, J.Y.
6-Substituted Triazolyl Benzoxaboroles as Selective Carbonic Anhydrase Inhibitors: In Silico Design, Synthesis, and X-ray Crystallography.
J.Med.Chem., 66:8118-8129, 2023
Cited by
PubMed Abstract: Benzoxaborole is currently a scaffold of great relevance in medicinal chemistry. In 2016, it was reported to be a new and valuable chemotype for designing carbonic anhydrase (CA) inhibitors. Herein, using an design, we report the synthesis and characterization of substituted 6-(1-1,2,3-triazol-1-yl)benzoxaboroles. 6-Azidobenzoxaborole was described for the first time as a molecular platform to prepare libraries of inhibitors by a copper(I)-catalyzed azide-alkyne cycloaddition a click chemistry strategy. With inhibition constants below 30 nM, some derivatives, such as compound , showed efficacy as selective hCA VII and IX inhibitors. The design hypothesis was validated by crystallographic investigation on the hCA II/ adduct, which provided explanations over the different inhibition behavior observed against the five evaluated hCA isoforms. Overall, this study identified as a new promising lead compound to develop novel anticancer agents targeting the tumor-associated hCA IX but also potent neuropathic pain relievers targeting hCA VII.
PubMed: 37283561
DOI: 10.1021/acs.jmedchem.3c00433
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.22 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon